Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity

Journal of General Virology

Volumn 79, Issue 6, 1998, Pages 1373-1381

  Duverlie, Gilles ^a   Khorsi, Hafida ^a   Castelain, Sandrine ^a   Jaillon, Olivier ^a   Izopet, Jacques ^b   Lunel, Françoise ^c   Eb, François ^a   Penin, François ^d   Wychowski, Czeslaw ^e  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b CHU PURPAN   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^e INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONSENSUS SEQUENCE; DRUG SENSITIVITY; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS; VIRUS RESISTANCE;

HEPATITIS C VIRUS; HEPATITIS C VIRUS TYPE 1;

EID: 0031836249     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-6-1373     Document Type: Article

References (38)

1. Asabe, S. I., Tanji, Y., Satoh, S., Kaneko, T., Kimura, K. & Shimotohno, K. (1997). The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. Journal of Virology 71, 790-796.
2. Bairoch, A. (1993). The PROSITE dictionary of sires and patterns in proteins, its current status. Nucleic Acids Research 21, 3097-3103.
3. Castelain, S., Khorsi, H., Zawadzki, P., Sueur, J. M., Capron, J. P., Eb, F. & Duverlie, G. (1997). Direct blotting electrophoresis for sequencing and genotyping hepatitis C virus. Journal of Virological Methods 65, 237-243.
4. Chamberlain, R. W., Adams, N. J., Taylor, L. A., Simmonds, P. & Elliott, R. M. (1997). The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochemical and Biophysical Research Communications 236, 44-49.
5. Chayama, K., Tsubota, A., Kobayashi, M., Okamoto, K., Hashimoto, M., Miyano, Y., Koike, H., Kobayashi, M., Koida, I., Arase, Y., Saitoh, S., Suzuki, Y., Murashima, N., Ikeda, K. & Kumada, H. (1997). Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25, 745-749.
6. Chou, P. & Fasman, G. D. (1978). Prediction of the secondary structure of proteins from their amino acid sequence. Advances in Enzymology 47, 45-148.
7. Deléage, G. & Roux, B. (1987). An algorithm for protein secondary structure prediction based on class prediction. Protein Engineering 1, 289-294.
8. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F. & Sato, C. (1995). Comparison of full-length sequences of Interferon-sensitive and resistant hepatitis C virus 1b - sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96, 224-230.
9. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F. & Sato, C. (1996). Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334, 77-81.
10. Felsenstein, J. (1993). PHYLIP: Phylogeny interference package, version 3.5c. Department of Genetics, University of Washington, Seattle, WA, USA.
11. Gale, M. J., Korth, M. J., Tang, N. M., Tan, S. L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R. & Katze, M. G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227.
12. Geourjon, C. & Deléage, G. (1995). ANTHEPROT 2.0: A three-dimensional module fully coupled with protein sequence analysis methods. Journal of Molecular Graphics 13, 209-212.
13. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67, 1385-1395.
14. Herion, D. & Hoofnagle, J. H. (1997). The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 25, 769-771.
15. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M. & Shimotohno, K. (1991). Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences, USA 88, 5547-5551.
16. Hofgärtner, W. T., Polyak, S. J., Sullivan, D. G., Carithers, R. L. & Gretch, D. R. (1997). Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. Journal of Medical Virology 53, 118-126.
17. Hoofnagle, J. H. & DiBisceglie, A.M. (1997). Drug therapy: the treatment of chronic viral hepatitis. New England Journal of Medicine 336, 347-356.
18. Ide, Y., Zhang, L. W., Chen, M., Inchauspe, G., Bahl, C., Sasaguri, Y. & Padmanabhan, R. (1996). Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstnictural protein NS5A. Gene 182, 203-211.
19. Inchauspé, G., Zebedee, S., Lee, D. H., Sugitani, M., Nasoff, M. & Prince, A. M. (1991). Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proceedings of the National Academy of Sciences, USA 88, 10292-10296.
20. Jakschies, D., Zachoval, R., Muller, R., Manns, M., Nolte, K. U., Hochkeppel, H. K., Horisberger, M. A., Deicher, H. & Vonwussow, P. (1994). Strong transient expression of the type I interferon induced MxA protein in hepatitis A but not in acute hepatitis B and hepatitis C. Hepatalogy 19, 857-865.
21. Kaneko, T., Tanji, Y., Satoh, S., Hijikata, M., Asabe, S., Kimura, K. & Shimotohno, K. (1994). Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochemical and Biophysical Research Communications 205, 320-326.
22. Kato, N., Lan, K. H., Ononita, S. K., Shiratori, Y. & Omata, M. (1997). Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. Journal of Virology 71, 8856-8859.
23. Khorsi, H., Castelain, S., Wyseur, A., Izopet, J., Canva, V., Rombout, A., Capron, D., Capron, J. P., Lunel, F., Stuyver, L. & Duverlie, G. (1997). Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alfa therapy in French patients. Journal of Hepatology 27, 72-77.
24. Kurosaki, M., Enomoto, N., Murakami, T., Sakuma, I., Asahina, Y., Yamamoto, C., Ikeda, T., Tozuka, S., Izumi, M., Marumo, F. & Sato, C. (1997). Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 25, 750-753.
25. Maertens, G. & Stuyver, L. (1997). Genotypes and genetic variation of hepatitis C virus. In The Molecular Medicine of Viral Hepatitis, pp. 183-233. Edited by T. J. Harrison & A. J. Zuckerman. In Molecular Medical Science Series. Edited by K. James & A. Morris. Chichester: John Wiley.
26. Maertens, G. & Stuyver, L. (1997). Genotypes and genetic variation of hepatitis C virus. In The Molecular Medicine of Viral Hepatitis, pp. 183-233. Edited by T. J. Harrison & A. J. Zuckerman. In Molecular Medical Science Series. Edited by K. James & A. Morris. Chichester: John Wiley.
27. Major, M. E. & Feinstone, S. M. (1997). The molecular virology of hepatitis C. Hepatology 25, 1527-1538.
28. Markland, W., Petrillo, R. A., Fitzgibbon, M., Fox, T., McCarrick, R., McQuaid, T., Fulghum, J. R., Chen, W., Fleming, M. A., Thomson, J. A. & Chambers, S. P. (1997). Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae. Journal of General Virology 78, 39-43.
29. Martinot-Peignoux, M., Marcellin, P., Pouteau, M., Castelnau, C., Boyer, N., Poliquin, M., Degott, C., Descombes, I., Lebreton, V., Milotova, V., Benhamou, J. P. & Erlinger, S. (1995). Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to Interferon alfa therapy in chronic hepatitis C. Hepatology 22, 1050-1056.
30. Nakashima, H., Nishikawa, K. & Ooi, T. (1986). The folding type of a protein is relevant to the amino acid composition. Journal of Biochemistry (Tokyo) 99, 153-162.
31. Reed, K. E., Xu, J. & Rice, C. M. (1997). Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. Journal of Virology 71, 7187-7197.
32. Smith, D. B., McAllister, J., Casino, C. & Simmonds, P. (1997). Virus 'quasispecies': making a mountain out of a molehill? Journal of General Virology 78, 1511-1519.
33. Squadrito, G., Leone, F., Sartori, M., Nalpas, B., Berthelot, P., Raimondo, G., Pol, S. & Brechot, C. (1997). Mutations in the nonstructural SA region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113, 567-572.
34. Tanimoto, A., Ide, Y., Arima, N., Sasaguri, Y. & Padmanabhan, R. (1997). The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochemical and Biophysical Research Communications 236, 360-364.
35. Tanji, Y., Kaneko, T., Satoh, S. & Shimotohno, K. (1995). Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. Journal of Virology 69, 3980-3986.
36. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight-matrix choice. Nucleic Acids Research 22, 4673-4680.
37. Tong, M. J., Elfarra, N. S., Reikes, A. R. & Co, R. L. (1995). Clinical outcomes after transfusion-associated hepatitis C. New England Journal of Medicine 332, 1463-1466.
38. Zeuzem, S., Lee, J. H. & Roth, W. K. (1997). Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25, 740-744.